GlassScriptPhysician profile
Caryn Van Deventer
NPI 1467840546
$2,504.70
in general payments reported to CMS, 2019-2025
43 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $39.34 · 2021: $404 · 2022: $448 · 2023: $378 · 2024: $712 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,311 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,310.91 |
| Education | $169.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $295.24 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $263.43 | 2024-2025 | Veozah |
| Pfizer INC. | $252.97 | 2021-2024 | |
| Exeltis, USA INC. | $168.25 | 2021-2025 | Slynd |
| Sage Therapeutics, LLC | $119.78 | 2023-2025 | Zurzuvae |
| Organon LLC | $104.04 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $85.70 | 2021-2025 | |
| Agile Therapeutics, INC. | $64.23 | 2022-2024 | Twirla |
| Sumitomo Pharma America, INC. | $61.82 | 2023-2024 | Myfembree |
| Millicent US INC | $61.35 | 2021-2025 | Intrarosa, Femring, Femlyv |
| Intuitive Surgical, INC. | $58.24 | 2025 | |
| Hologic Sales and Service, LLC | $56.61 | 2024 | Aptima |
| Channel Medsystems, INC. | $56.13 | 2022 | |
| Minerva Surgical, INC | $52.49 | 2022-2025 | |
| Coopersurgical, INC. | $51.97 | 2019-2022 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $50.10 | 2023-2025 | Perclot, Tisseel |
| Applied Medical Resources Corporation | $47.67 | 2023 | |
| Dilon Technologies, INC. | $44.10 | 2025 | Hemoblast Bellows |
| Daiichi Sankyo INC. | $43.88 | 2022 | |
| Scynexis, INC. | $43.37 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $40.82 | 2019 | |
| Ethicon US, LLC | $40.45 | 2019-2022 | |
| Myovant Sciences INC. | $38.44 | 2021-2022 | |
| Integra Lifesciences Corporation | $36.14 | 2023-2024 | Medihoney, Biodfactor, Biodrestore |
| Medtronic, INC. | $35.52 | 2023-2025 | V-Loc 180, Venaseal |
| Mayne Pharma Commercial LLC | $34.86 | 2024-2025 | |
| Ascend Therapeutics US, LLC | $27.57 | 2021 | |
| Innovation Technologies INC | $22.11 | 2024 | Irrisept |
| Kerecis Limited | $21.30 | 2022 | |
| Mylan Pharmaceuticals INC. | $20.44 | 2022 | |
| Meditrina | $20.19 | 2025 | |
| Davol INC. | $19.40 | 2021 | |
| Glaxosmithkline, LLC. | $19.17 | 2025 | Shingrix, Arexvy |
| Trevena, INC. | $18.77 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.34 | 2021 | |
| Optumhealth Care Solutions, LLC | $18.25 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Heron Therapeutics, INC. | $15.88 | 2024 | Zynrelef |
| Kci USA, INC. | $14.83 | 2019 | |
| Avion Pharmaceuticals | $14.22 | 2023 | Balcoltra |
| Medicem INC. | $13.62 | 2021 | |
| Convatec INC. | $12.47 | 2021 | |
| Becton, Dickinson and Company | $11.36 | 2021 | |
| Mission Pharmacal Company | $9.18 | 2024 | Citranatal Medley |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caryn Van Deventer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.